<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">Genetic reagent <break/>(<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(kdrl:HsHRAS-mCherry)<sup>s896</sup></italic></td><td valign="top">DOI:10.1101/gad.1629408</td><td valign="top">ZFIN ID: ZDB- <break/>ALT-081212&#8211;4</td><td valign="top">Transgenic insertion</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(fli1a:EGFP)<sup>y1</sup></italic></td><td valign="top">PMID:12167406</td><td valign="top">ZFIN ID: ZDB- <break/>ALT-011017&#8211;8</td><td valign="top">Transgenic insertion</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(fli1a:GAL4FF)<sup>ubs4</sup></italic></td><td valign="top">DOI:10.1016/j.devcel. <break/>2011.06.033</td><td valign="top">ZFIN ID: ZDB- <break/>ALT-110921&#8211;1</td><td valign="top">Transgenic insertion</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>Danio rerio</italic>)</td><td valign="top"><italic>Tg(flt1:nlsmCherry)<sup>skt7</sup></italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top">Transgenic insertion. <break/>Made using Torres-V&#225;zquez <break/>lab plasmid #1208</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>Danio rerio</italic>)</td><td valign="top"><italic>gipc1<sup>skt1</sup></italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top">Putative null mutant allele</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>Danio rerio</italic>)</td><td valign="top"><italic>gipc1<sup>skt2</sup></italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top">Putative null mutant allele</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>Danio rerio</italic>)</td><td valign="top"><italic>gipc2<sup>skt3</sup></italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top">Putative null mutant allele</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>Danio rerio</italic>)</td><td valign="top"><italic>gipc2<sup>skt4</sup></italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top">Putative null mutant allele</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>Danio rerio</italic>)</td><td valign="top"><italic>gipc3<sup>skt5</sup></italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top">Putative null mutant allele</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>Danio rerio</italic>)</td><td valign="top"><italic>plxnd1<sup>fov01b</sup></italic></td><td valign="top">PMID: 11861480 <break/>DOI:10.1016/j.devcel. <break/>2004.06.008</td><td valign="top">ZFIN ID: ZDB-ALT <break/>-010621&#8211;6</td><td valign="top">Null mutant allele <break/>(point mutation)</td></tr><tr><td valign="top">Genetic reagent <break/>(<italic>Danio rerio</italic>)</td><td valign="top"><italic>plxnd1<sup>skt6</sup></italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top">Hypermorphic mutant <break/>allele</td></tr><tr><td valign="top">Cell line <break/>(<italic>Cercopithecus aethiops</italic>)</td><td valign="top">COS-7 (Monkey <break/>Kidney Fibroblasts)</td><td valign="top">American Type <break/>Culture Collection</td><td valign="top">Cat. #CRL-1651. <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0224">CVCL_0224</ext-link></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.atcc.org/products/All/CRL-1651.aspx">https://www.atcc.org/products/All/CRL-1651.aspx</ext-link></td></tr><tr><td valign="top">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td valign="top">HUVEC/TERT2 <break/>(Immortalized Human <break/>Umbilical Vein Endothelial <break/>Cells)</td><td valign="top">American Type <break/>Culture Collection</td><td valign="top">Cat. #CRL-4053. <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_9Q53">CVCL_9Q53</ext-link></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.atcc.org/Products/All/CRL-4053.aspx">https://www.atcc.org/Products/All/CRL-4053.aspx</ext-link></td></tr><tr><td valign="top">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td valign="top">HUVEC (Normal <break/>Primary Human Umbilical <break/>Vein Endothelial Cells)</td><td valign="top">Lifeline Cell Technology</td><td valign="top">Cat. #FC-0003</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.lifelinecelltech.com/shop/cells/human-endothelial-cells/umbilical-vein-endothelial-cells/huvec-fc-0003/">https://www.lifelinecelltech.com/shop/cells/human-endothelial-cells/umbilical-vein-endothelial-cells/huvec-fc-0003/</ext-link></td></tr><tr><td valign="top">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td valign="top">Non-targeting gRNA1. <break/>Pool of HUVEC/TERT2 <break/>cells.</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Derived from HUVEC/TERT <break/>2 cell line (ATCC CRL4053). <break/>Cells were grown under blasticidin <break/>(4 &#956;g/ml) selection and used <break/>between 7th&#160;and&#160;10th passages. <break/>Cells stably coexpress <break/>Cas9 nuclease and non-targeting <break/>gRNA1 (from Torres-V&#225;zquez <break/>lab plasmid #1859)</td></tr><tr><td valign="top">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td valign="top">Non-targeting gRNA2. <break/>Pool of HUVEC/TERT2 <break/>cells.</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Derived from HUVEC/TERT <break/>2 cell line (ATCC CRL4053). <break/>Cells were grown under <break/>blasticidin (4 &#956;g/ml) selection <break/>and used between 7th-10th <break/>passages. <break/>Cells are stably coexpressing <break/>Cas9 nuclease and non- <break/>targeting gRNA2 (from <break/>Torres-V&#225;zquez lab plasmid #1860)</td></tr><tr><td valign="top">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td valign="top"><italic>PLXND1</italic> gRNA KO1. <break/>Monoclonal <italic>PLXND1</italic> KO <break/>HUVEC/TERT2 cell line.</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Biallelic (transheterozygous) <break/><italic>PLXND1</italic> knockout line. Derived <break/>from HUVEC/TERT 2 cell line <break/>(ATCC CRL4053). Cells were <break/>grown under blasticidin (4 &#956;g/ml) <break/>selection and used between <break/>7th-10th passages. <break/>Cells are stably coexpressing <break/>Cas9 nuclease and <italic>PLXND1</italic> <break/>gRNA KO1 (from Torres-V&#225;zquez <break/>lab plasmid #1846)</td></tr><tr><td valign="top">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td valign="top"><italic>PLXND1</italic> gRNA KO2. <break/>Monoclonal <italic>PLXND1</italic> KO <break/>HUVEC/TERT2 cell line.</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Biallelic (transheterozygous) <break/><italic>PLXND1</italic> knockout line. Derived <break/>from HUVEC/TERT 2 cell line <break/>(ATCC CRL4053). Cells were <break/>grown under blasticidin (4 &#956;g/ml) <break/>selection and used between <break/>7th-10th passages. <break/>Cells are stably coexpressing <break/>Cas9 nuclease and <italic>PLXND1</italic> <break/>gRNA KO2 (from Torres-V&#225;zquez <break/>lab plasmid # 1847)</td></tr><tr><td valign="top">Cell line <break/>(<italic>Homo sapiens</italic>)</td><td valign="top">HEK293T <break/>(embryonic kidney cells)</td><td valign="top">Matthias <break/>Stadtfeld lab, NYU</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">V5-C-mPLXND1<sup>WT</sup></td><td valign="top">This paper</td><td valign="top"/><td valign="top">Torres-V&#225;zquez lab <break/>plasmid #862. Vector <break/>backbone: <italic>pcDNA3.1/</italic> <break/><italic>nV5-DEST-V5</italic></td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">V5-C-mPLXND1&#916;<sup>CYSEA</sup></td><td valign="top">This paper</td><td valign="top"/><td valign="top">Torres-V&#225;zquez lab <break/>plasmid #863. Vector <break/>backbone: <italic>pcDNA3.1/</italic> <break/><italic>nV5-DEST-V5</italic></td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">V5-C-mPLXND1&#916;<sup>GBM</sup></td><td valign="top">This paper</td><td valign="top"/><td valign="top">Torres-V&#225;zquez lab <break/>plasmid #1774. Vector <break/>backbone: <italic>pcDNA3.1/</italic> <break/><italic>nV5-DEST-V5</italic></td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">FLAG-mGIPC1<sup>WT</sup></td><td valign="top">DOI:10.1091/mbc.12.3.615</td><td valign="top"/><td valign="top">Torres-V&#225;zquez lab <break/>plasmid #864. Vector <break/>backbone: <italic>pFLAG-CMV1</italic></td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">FLAG-mGIPC1<sup>GH1</sup></td><td valign="top">DOI:10.1091/mbc.12.3.615</td><td valign="top"/><td valign="top">Torres-V&#225;zquez lab <break/>plasmid #868. Vector <break/>backbone: <italic>pFLAG-CMV2</italic></td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">FLAG-mGIPC1<sup>PDZ</sup></td><td valign="top">DOI:10.1091/mbc.12.3.615</td><td valign="top"/><td valign="top">Torres-V&#225;zquez lab <break/>plasmid #866. Vector <break/>backbone: <italic>pFLAG-CMV3</italic></td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">2xHA-Plxnd1<sup>WT</sup></td><td valign="top">This paper</td><td valign="top"/><td valign="top">GAL4-responsive, <break/>Gateway and <italic>IRES</italic>-based <break/>bicistronic vector for <italic>Tol2</italic>- <break/>mediated zebrafish transgenesis. <break/>Torres-V&#225;zquez lab plasmid #1414</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">2xHA-Plxnd1&#916;<sup>GBM</sup></td><td valign="top">This paper</td><td valign="top"/><td valign="top">GAL4-responsive, Gateway <break/>and <italic>IRES</italic>-based bicistronic <break/>vector for <italic>Tol2</italic>-mediated <break/>zebrafish transgenesis. <break/>Torres-V&#225;zquez lab plasmid #1685</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">lentiCRISPR v2-Blast</td><td valign="top">Addgene</td><td valign="top">Cat. #83480</td><td valign="top">A gift from Mohan Babu. <break/><ext-link ext-link-type="uri" xlink:href="https://www.addgene.org/83480/">https://www.addgene.org/83480/</ext-link></td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">Non-targeting gRNA1</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Torres-V&#225;zquez lab <break/>plasmid #1859. Vector <break/>backbone: lentiCRISPR <break/>v2-Blast</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">Non-targeting gRNA2</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Torres-V&#225;zquez lab <break/>plasmid #1860. Vector <break/>backbone: lentiCRISPR <break/>v2-Blast</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">PLXND1-KO1</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Torres-V&#225;zquez lab <break/>plasmid #1846. Vector <break/>backbone: lentiCRISPR v2-Blast</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">PLXND1-KO2</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Torres-V&#225;zquez lab <break/>plasmid #1847. Vector <break/>backbone: lentiCRISPR v2-Blast</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">Control shRNA Lentiviral <break/>Particles-A (Non-targeting <break/>control shRNA)</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat. #sc-108080</td><td valign="top">Encodes a non-targeting <break/>shRNA sequence, will not <break/>lead to the specific degradation <break/>of any known cellular mRNA</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">GIPC shRNA (h) <break/>Lentiviral Particles</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat. #sc-35475-V</td><td valign="top">shRNA pool (three <break/>target-specific constructs <break/>against human <italic>GIPC1</italic> that <break/>encode 19&#8211;25 nt <break/>(plus hairpin) shRNAs). <break/>Target sequences <break/>(sense sequences 5&#8217; to 3&#8217;): <break/>(1) CUGACGAGUUCGUCUUUGA <break/>(2) CCACCACUUUCCACCAUCA <break/>(3) CUGAAUUUGCUGUCUUGAA</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">GIPC2 shRNA (h) <break/>Lentiviral Particles</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat. # sc-75132-V</td><td valign="top">shRNA pool (three <break/>target-specific constructs <break/>against human <italic>GIPC2</italic> that <break/>encode 19&#8211;25 nt (plus hairpin) <break/>shRNAs). Target sequences <break/>(sense sequences 5&#8217; to 3&#8217;): <break/>(1) CAGACGAAUUUGUCUUUGA <break/>(2) GGACACCUUUACUAACUCU <break/>(3) CCAACUUUCUCUCUUUGUA</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">GIPC3 shRNA (h) <break/>Lentiviral Particles</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat. #sc-62376-V</td><td valign="top">shRNA pool (three <break/>target-specific constructs <break/>against human <italic>GIPC3</italic> that <break/>encode 19&#8211;25 nt (plus hairpin) <break/>shRNAs). Target sequences <break/>(sense sequences 5&#8217; to 3&#8217;): <break/>(1) CCUUCAUCAAGAGAAUCAA <break/>(2) GGAGUUUGCACGCUGUUUA <break/>(3) GACAAGUUCCUCUCUAGAA</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">Plexin-D1 shRNA <break/>(h) Lentiviral Particles</td><td valign="top">Santa Cruz <break/>Biotechnology</td><td valign="top">Cat. #sc-45585-V</td><td valign="top">shRNA pool (three <break/>target-specific constructs <break/>against human <italic>PLXND1</italic> that <break/>encode 19&#8211;25 nt (plus hairpin) <break/>shRNAs). Target sequences (sense <break/>sequences 5&#8217; to 3&#8217;): <break/>(1) GUCAAGAUAGGCCAAGUAA <break/>(2) CCAUGAGUCUCAUAGACAA <break/>(3) CCACAGACAGUUUCAAGUA</td></tr><tr><td valign="top">Sequenced-based <break/>reagent</td><td valign="top"><italic>plxnd1<sup>3207-3462</sup></italic> morpholino</td><td valign="top">DOI:10.1016/j.devcel. <break/>2004.06.008</td><td valign="top"/><td valign="top">Validated splice-blocking <break/>morpholino against zebrafish <break/><italic>plxnd1</italic>. Synthesized by <break/>GENE TOOLS, LLC). <break/>Sequence (5&#8217; to 3&#8217;): <break/>CACACACACTCACGTTGATGATGAG</td></tr><tr><td valign="top">Antibody</td><td valign="top">Chicken anti-GFP</td><td valign="top">Invitrogen</td><td valign="top">Cat. #A10262</td><td valign="top">IF (1:1,000); zebrafish</td></tr><tr><td valign="top">Antibody</td><td valign="top">Sheep anti-mCherry</td><td valign="top">Holger Knaut lab, NYU</td><td valign="top"/><td valign="top">IF (1:1,000); zebrafish. <break/>Custom made antibody</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse anti-pFAK Tyr397</td><td valign="top">Millipore</td><td valign="top">Cat. #05&#8211;1140</td><td valign="top">IF (1:1,000); zebrafish</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit anti-GIPC1</td><td valign="top">Proteintech Group</td><td valign="top">Cat. #14822&#8211;1-AP. <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2263269">AB_2263269</ext-link></td><td valign="top">WB (1:3,000). This antibody <break/>detects GIPC1, GIPC2, <break/>and GIPC3 (our data)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit anti-GIPC2</td><td valign="top">Abcam</td><td valign="top">Cat. #ab175272</td><td valign="top">WB (1:5,000). This antibody <break/>detects GIPC1 and <break/>GIPC2 (our data)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit anti-GIPC3</td><td valign="top">Abcam</td><td valign="top">Cat. #ab186426</td><td valign="top">WB (1:5000). This antibody <break/>is specific for GIPC3 (our data). <break/>Validated against HeLa TCL <break/>(positive control; a gift from <break/>Mamta Tahiliani&#8217;s lab, NYU)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse anti-PLXND1</td><td valign="top">R and D Systems</td><td valign="top">Cat. #MAB41601 <break/>Clone #752815</td><td valign="top">WB (1:250). Lyophilized <break/>reagent reconstituted in <break/>200 &#956;l of sterile PBS <break/>(GIBCO, Cat. #10010&#8211;023)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit anti-Phospho- <break/>p44/42 MAPK (Erk1/2) <break/>(Thr202/Tyr204) (D13.14.4E) <break/>XPTM</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat. #4370S. <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2315112">AB_2315112</ext-link></td><td valign="top">WB (1:20,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse anti-p44/42 <break/>MAPK (Erk1/2) (L34F12)</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat. #4696S</td><td valign="top">WB (1:10,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit anti-GAPDH <break/>(D16H11)</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat. #5174P. <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10622025">AB_10622025</ext-link></td><td valign="top">WB (1:20,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse anti-FLAG M2</td><td valign="top">SIGMA-ALDRICH</td><td valign="top">Cat. #F3165, <break/>clone M2. <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_259529">AB_259529</ext-link></td><td valign="top">WB (1:20,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit anti-V5-Tag <break/>(D3H8Q)</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat. #13202S. <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2687461">AB_2687461</ext-link></td><td valign="top">WB (1:10,000)</td></tr><tr><td valign="top">Peptide, <break/>recombinant protein</td><td valign="top">Human Semaphorin 3E</td><td valign="top">R and D Systems</td><td valign="top">Cat. #3239-S3B</td><td valign="top">Working concentration <break/>of 2 nM (prepared in 1xPBS <break/>with 0.1%BSA (SIGMA_ALDRICH, <break/>Cat.A8022)</td></tr><tr><td valign="top">Chemical <break/>compound, drug</td><td valign="top">SU5416</td><td valign="top">SIGMA-ALDRICH</td><td valign="top">Cat. #S8442</td><td valign="top">Working concentration <break/>of 0.2 &#956;M in fish water. <break/>From 10.5 mM stock solution <break/>in DMSO (SIGMA-ALDRICH, <break/>Cat. #D8418)</td></tr><tr><td valign="top">Chemical <break/>compound, drug</td><td valign="top">Gelatin, from porcine skin</td><td valign="top">SIGMA-ALDRICH</td><td valign="top">Cat. # G1890-100G</td><td valign="top">Working concentration <break/>of 0.1% (prepared in distilled <break/>water and then autoclaved)</td></tr><tr><td valign="top">Chemical <break/>compound, drug</td><td valign="top">Blasticidin S HCl, powder</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat. #R21001</td><td valign="top">From a stock solution <break/>of 10 mg/ml. Prepared in <break/>UltraPure Distilled water <break/>(Invitrogen Cat. # 10977&#8211;015)</td></tr><tr><td valign="top">Chemical <break/>compound, drug</td><td valign="top">Puromycin Dihydrochloride</td><td valign="top">ThermoFisher Scientific</td><td valign="top">Cat. #A1113803</td><td valign="top">From a stock solution of 10 mg/ml</td></tr></tbody></table></table-wrap>